semaglutide canada patent expiry Novo Nordisk lets key Ozempic lapse in Canada, despite being world's second-largest market – ip fray Novo Nordisk Lets Canadian Semaglutide
Description
On Retatrutide, a modified version with added protein is recommended
Buyers who have been prescribed or are considering prescription GLP-1 therapy should continue that conversation with their healthcare provider - and shouldn't use GLPatch as a reason to delay or avoid it
The primary endpoint should be measurable, sensitive to change, clinically meaningful, and be able to be quantified consistently
Learn More Featured
Saxenda European Medicines Agency
